This review looked at the role of a specific protein called CD23 (also known as FcεRII) in skin conditions such as atopic dermatitis, chronic spontaneous urticaria, and bullous pemphigoid. The research focused on how this protein helps regulate IgE levels, which are often involved in allergic reactions.
Researchers found that CD23 usually plays a regulatory role in maintaining balance. However, when it becomes soluble, it may actually help increase inflammatory signals in certain situations. In dermatology specifically, the amount of circulating soluble CD23 is often linked to total IgE levels and how active a patient's disease is.
Because this was a narrative review based on existing literature, the findings are not yet enough to confirm CD23 as a proven treatment or a standard test for doctors. More research is needed to fully understand its role before it can be used in clinical practice. For now, these results suggest that CD23 could eventually become an important target for new treatments.
